| Year |
Citation |
Score |
| 2024 |
Wei J, Ning H, Ramos-Espinosa O, Eickhoff CS, Hou R, Wang Q, Fu M, Liu EY, Fan D, Hoft DF, Liu J. Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages. Faseb Bioadvances. 6: 249-262. PMID 39114448 DOI: 10.1096/fba.2024-00022 |
0.31 |
|
| 2024 |
Hill-Batorski L, Weiner JA, Ackerman ME, Hatta Y, Hoft DF, Herber R, Moser MJ, Bilsel P. Intranasal M2SR (M2-deficient Single Replication) Influenza Vaccine Induces Broadly Reactive Mucosal Antibody Production in Adults. The Journal of Infectious Diseases. PMID 39012796 DOI: 10.1093/infdis/jiae361 |
0.35 |
|
| 2024 |
Balasingam S, Dheda K, Fortune S, Gordon SB, Hoft D, Kublin JG, Loynachan CN, McShane H, Morton B, Nambiar S, Sharma NR, Robertson B, Schrager LK, Weller CL. Review of the current TB human infection studies for use in accelerating TB vaccine development: A meeting report. The Journal of Infectious Diseases. PMID 38709726 DOI: 10.1093/infdis/jiae238 |
0.355 |
|
| 2023 |
Silver RF, Xia M, Storer CE, Jarvela JR, Moyer MC, Blazevic A, Stoeckel DA, Rakey EK, Tennant JM, Goll JB, Head RD, Hoft DF. Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination. Nature Communications. 14: 8507. PMID 38129388 DOI: 10.1038/s41467-023-44136-8 |
0.438 |
|
| 2023 |
Blazevic A, Edwards RL, Xia M, Eickhoff CS, Hamzabegovic F, Meza KA, Ning H, Tennant J, Mosby KJ, Ritchie JC, Girmay T, Lai L, McCullough M, Beck A, Kelley C, ... ... Hoft DF, et al. Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo. The Journal of Infectious Diseases. PMID 38019956 DOI: 10.1093/infdis/jiad441 |
0.329 |
|
| 2023 |
Eickhoff CS, Meza KA, Terry FE, Colbert CG, Blazevic A, Gutiérrez AH, Stone ET, Brien JD, Pinto AK, El Sahly HM, Mulligan MJ, Rouphael N, Alcaide ML, Tomashek KM, Focht C, ... ... Hoft DF, et al. Identification of immunodominant T cell epitopes induced by natural Zika virus infection. Frontiers in Immunology. 14: 1247876. PMID 37705976 DOI: 10.3389/fimmu.2023.1247876 |
0.388 |
|
| 2023 |
Xia M, Blazevic A, Fiore-Gartland A, Hoft DF. Impact of BCG vaccination on the repertoire of human γδ T cell receptors. Frontiers in Immunology. 14: 1100490. PMID 37056780 DOI: 10.3389/fimmu.2023.1100490 |
0.467 |
|
| 2023 |
Hoft SG, Kauffman KD, Sakai S, Lindestam Arlehamn CS, Sette A, Hoft DF, Herbert R, Barber DL. Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques. Mbio. e0022023. PMID 36880755 DOI: 10.1128/mbio.00220-23 |
0.463 |
|
| 2023 |
Sagawa ZK, Goman C, Frevol A, Blazevic A, Tennant J, Fisher B, Day T, Jackson S, Lemiale F, Toussaint L, Kalisz I, Jiang J, Ondrejcek L, Mohamath R, Vergara J, ... ... Hoft DF, et al. Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults. Nature Communications. 14: 1138. PMID 36878897 DOI: 10.1038/s41467-023-36789-2 |
0.402 |
|
| 2022 |
Cai CW, O'Shea A, Eickhoff CS, Guo H, Lewis WG, Beverley SM, Hoft DF. Use of parasites expressing a recombinant antigen as live vaccines against Chagas disease. Frontiers in Microbiology. 13: 1059115. PMID 36523834 DOI: 10.3389/fmicb.2022.1059115 |
0.325 |
|
| 2022 |
Gela A, Murphy M, Rodo M, Hadley K, Hanekom WA, Boom WH, Johnson JL, Hoft DF, Joosten SA, Ottenhoff THM, Suliman S, Moody DB, Lewinsohn DM, Hatherill M, Seshadri C, et al. Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies. Ebiomedicine. 76: 103839. PMID 35149285 DOI: 10.1016/j.ebiom.2022.103839 |
0.451 |
|
| 2021 |
Eiden J, Gordon G, Fierro C, Herber R, Aitchison R, Belshe R, Greenberg H, Hoft D, Hatta Y, Moser MJ, Tary-Lehmann M, Kawaoka Y, Neumann G, Radspinner P, Bilsel P. Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults. Vaccines. 9. PMID 34960134 DOI: 10.3390/vaccines9121388 |
0.319 |
|
| 2021 |
Rasi V, Wood DC, Eickhoff CS, Xia M, Pozzi N, Edwards RL, Walch M, Bovenschen N, Hoft DF. Granzyme A Produced by γδ T Cells Activates ER Stress Responses and ATP Production, and Protects Against Intracellular Mycobacterial Replication Independent of Enzymatic Activity. Frontiers in Immunology. 12: 712678. PMID 34413857 DOI: 10.3389/fimmu.2021.712678 |
0.351 |
|
| 2021 |
Cai CW, Eickhoff CS, Meza KA, Blase JR, Audette RE, Chan DH, Bockerstett KA, DiPaolo RJ, Hoft DF. Th17 cells provide mucosal protection against gastric infection. Infection and Immunity. PMID 33941576 DOI: 10.1128/IAI.00738-20 |
0.41 |
|
| 2021 |
Liu X, Hartman CL, Li L, Albert CJ, Si F, Gao A, Huang L, Zhao Y, Lin W, Hsueh EC, Shen L, Shao Q, Hoft DF, Ford DA, Peng G. Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine. 13. PMID 33790024 DOI: 10.1126/scitranslmed.aaz6314 |
0.306 |
|
| 2020 |
Moise L, Ross TM, Hoft DF, Martin WD, De Groot AS. "Mindful" development of rapid, safe and effective COVID-19 vaccines. Expert Review of Vaccines. PMID 32962468 DOI: 10.1080/14760584.2020.1825946 |
0.468 |
|
| 2020 |
Peng H, Ning H, Wang Q, Lai J, Wei L, Stumpo DJ, Blackshear PJ, Fu M, Hou R, Hoft DF, Liu J. Tristetraprolin Regulates T17 Cell Function and Ameliorates DSS-Induced Colitis in Mice. Frontiers in Immunology. 11: 1952. PMID 32922402 DOI: 10.3389/Fimmu.2020.01952 |
0.438 |
|
| 2020 |
Maner-Smith KM, Goll JB, Khadka M, Jensen TL, Colucci JK, Gelber CE, Albert CJ, Bosinger SE, Franke JD, Natrajan M, Rouphael N, Johnson RA, Sanz P, Anderson EJ, Hoft DF, et al. Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination. Vaccines. 8. PMID 32722213 DOI: 10.3390/Vaccines8030414 |
0.441 |
|
| 2020 |
Chang YH, Duong DM, Goll JB, Wood DC, Jensen TL, Yin L, Gelber CE, Seyfried NT, Anderson E, Natrajan MS, Rouphael N, Johnson RA, Sanz P, Mulligan MJ, Hoft DF. Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine. Vaccines. 8. PMID 32722207 DOI: 10.3390/Vaccines8030413 |
0.455 |
|
| 2020 |
Goll JB, Li S, Edwards JL, Bosinger SE, Jensen TL, Wang Y, Hooper WF, Gelber CE, Sanders KL, Anderson EJ, Rouphael N, Natrajan MS, Johnson RA, Sanz P, Hoft D, et al. Transcriptomic and Metabolic Responses to a Live-Attenuated Vaccine. Vaccines. 8. PMID 32722194 DOI: 10.3390/Vaccines8030412 |
0.515 |
|
| 2020 |
Bekeredjian-Ding I, Van Molle W, Baay M, Neels P, Conrad C, van Diepen A, Fortune S, Goetz K, Gorringe A, Hoft D, Johnson RA, Kremsner P, Krut O, Levy Y, et al. Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019. Biologicals : Journal of the International Association of Biological Standardization. PMID 32389512 DOI: 10.1016/J.Biologicals.2020.04.005 |
0.348 |
|
| 2020 |
De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, Hoft DF, Ross TM, Noe AR, Takahashi Y, Kotraiah V, Silk SE, Nielsen CM, Minassian AM, Ashfield R, et al. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology. 11: 442. PMID 32318055 DOI: 10.3389/Fimmu.2020.00442 |
0.522 |
|
| 2020 |
Liu X, Hoft DF, Peng G. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy. The Journal of Clinical Investigation. 130: 1073-1083. PMID 32118585 DOI: 10.1172/JCI133679 |
0.306 |
|
| 2019 |
Ji N, Mukherjee N, Morales EE, Tomasini ME, Hurez V, Curiel TJ, Abate G, Hoft DF, Zhao XR, Gelfond J, Maiti S, Cooper LJN, Svatek RS. Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial. Oncoimmunology. 8: 1614857. PMID 31413921 DOI: 10.1080/2162402X.2019.1614857 |
0.499 |
|
| 2019 |
Eickhoff CS, Blazevic A, Killoran EA, Morris MS, Hoft DF. Induction of mycobacterial protective immunity by sublingual BCG vaccination. Vaccine. PMID 31331776 DOI: 10.1016/J.Vaccine.2019.07.034 |
0.552 |
|
| 2019 |
Eickhoff CS, Terry FE, Peng L, Meza KA, Sakala IG, Van Aartsen D, Moise L, Martin WD, Schriewer J, Buller RM, De Groot AS, Hoft DF. Highly conserved influenza T cell epitopes induce broadly protective immunity. Vaccine. PMID 31331771 DOI: 10.1016/J.Vaccine.2019.07.033 |
0.508 |
|
| 2019 |
Yuan J, Tenant J, Pacatte T, Eickhoff C, Blazevic A, Hoft DF, Chatterjee S. A Subset of Mycobacteria-Specific CD4 IFN-γ T Cell Expressing Naive Phenotype Confers Protection against Tuberculosis Infection in the Lung. Journal of Immunology (Baltimore, Md. : 1950). PMID 31253726 DOI: 10.4049/Jimmunol.1900209 |
0.551 |
|
| 2019 |
Joosten SA, Ottenhoff THM, Lewinsohn DM, Hoft DF, Moody DB, Seshadri C. Harnessing donor unrestricted T-cells for new vaccines against tuberculosis. Vaccine. 37: 3022-3030. PMID 31040086 DOI: 10.1016/J.Vaccine.2019.04.050 |
0.561 |
|
| 2019 |
Abate G, Hamzabegovic F, Eickhoff CS, Hoft DF. BCG Vaccination Induces and Cross-Protective Immunity. Frontiers in Immunology. 10: 234. PMID 30837992 DOI: 10.3389/Fimmu.2019.00234 |
0.593 |
|
| 2018 |
Li L, Liu X, Sanders KL, Edwards JL, Ye J, Si F, Gao A, Huang L, Hsueh EC, Ford DA, Hoft DF, Peng G. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy. Cell Metabolism. PMID 30344014 DOI: 10.1016/J.Cmet.2018.09.020 |
0.408 |
|
| 2018 |
Bockerstett KA, Osaki LH, Petersen CP, Cai CW, Wong CF, Nguyen TM, Ford EL, Hoft DF, Mills JC, Goldenring JR, DiPaolo RJ. Interleukin-17A Promotes Parietal Cell Atrophy by Inducing Apoptosis. Cellular and Molecular Gastroenterology and Hepatology. 5: 678-690.e1. PMID 29930985 DOI: 10.1016/J.Jcmgh.2017.12.012 |
0.312 |
|
| 2018 |
De P, McNeil M, Xia M, Boot CM, Hesser DC, Denef K, Rithner C, Sours T, Dobos KM, Hoft D, Chatterjee D. Structural determinants in a glucose-containing lipopolysaccharide from critical for inducing a subset of protective T cells. The Journal of Biological Chemistry. PMID 29716995 DOI: 10.1074/Jbc.Ra118.002582 |
0.408 |
|
| 2018 |
Kozbial A, Bhandary L, Collier BB, Eickhoff CS, Hoft DF, Murthy SK. Automated generation of immature dendritic cells in a single-use system. Journal of Immunological Methods. PMID 29625078 DOI: 10.1016/J.Jim.2018.03.010 |
0.422 |
|
| 2018 |
Kwon YC, Meyer K, Peng G, Chatterjee S, Hoft DF, Ray R. Hepatitis C virus E2 envelope glycoprotein induces an immunoregulatory phenotype in macrophages. Hepatology (Baltimore, Md.). PMID 29443378 DOI: 10.1002/Hep.29843 |
0.36 |
|
| 2018 |
Liu X, Mo W, Ye J, Li L, Zhang Y, Hsueh EC, Hoft DF, Peng G. Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition. Nature Communications. 9: 249. PMID 29339767 DOI: 10.1038/S41467-017-02689-5 |
0.477 |
|
| 2018 |
Eiden J, Gordon G, Fierro C, Belshe R, Greenberg H, Hoft D, Hatta Y, Imboden M, Moser M, Herber R, Boltz D, Tary-Lehmann M, Kawaoka Y, Neumann G, Radspinner P, et al. 1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1626 |
0.432 |
|
| 2017 |
Modjarrad K, Lin L, George SL, Stephenson KE, Eckels KH, De La Barrera RA, Jarman RG, Sondergaard E, Tennant J, Ansel JL, Mills K, Koren M, Robb ML, Barrett J, Thompson J, ... ... Hoft DF, et al. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials. Lancet (London, England). PMID 29217375 DOI: 10.1016/S0140-6736(17)33106-9 |
0.413 |
|
| 2017 |
Wang Q, Ning H, Peng H, Wei L, Hou R, Hoft DF, Liu J. Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses. Nature Communications. 8: 867. PMID 29021521 DOI: 10.1038/S41467-017-00892-Y |
0.464 |
|
| 2017 |
Hoft DF, Xia M, Zhang GL, Blazevic A, Tennant J, Kaplan C, Matuschak G, Dube TJ, Hill H, Schlesinger LS, Andersen PL, Brusic V. PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4(+) T cell transcriptomal molecular signatures. Mucosal Immunology. PMID 28853442 DOI: 10.1038/Mi.2017.67 |
0.545 |
|
| 2017 |
Brennan MJ, Tanner R, Morris S, Scriba TJ, Achkar JM, Zelmer A, Hokey D, Izzo A, Sharpe S, Williams A, Penn-Nicholson A, Erasmus M, Stylianou E, Hoft DF, McShane H, et al. The Cross-species Mycobacterial Growth Inhibition Assay (MGIA) Project 2010-2014. Clinical and Vaccine Immunology : Cvi. PMID 28701467 DOI: 10.1128/Cvi.00142-17 |
0.438 |
|
| 2017 |
Blazevic A, Xia M, Turan A, Tennant J, Hoft DF. Pilot studies of a human BCG challenge model. Tuberculosis (Edinburgh, Scotland). 105: 108-112. PMID 28610781 DOI: 10.1016/J.Tube.2017.05.001 |
0.443 |
|
| 2017 |
Valentini D, Rao M, Rane L, Rahman S, Axelsson-Robertson R, Heuchel R, Löhr M, Hoft D, Brighenti S, Zumla A, Maeurer M. Peptide microarray-based characterisation of antibody responses to host proteins after Bacille Calmette-Guérin vaccination. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 28161459 DOI: 10.1016/J.Ijid.2017.01.027 |
0.464 |
|
| 2016 |
Hoft DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB. Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine (LAIV) and Inactivated Influenza Vaccine (IIV) in Adults. Clinical and Vaccine Immunology : Cvi. PMID 27847366 DOI: 10.1128/Cvi.00414-16 |
0.486 |
|
| 2016 |
Cai CW, Blase JR, Zhang X, Eickhoff CS, Hoft DF. Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi. Plos Pathogens. 12: e1005902. PMID 27695083 DOI: 10.1371/Journal.Ppat.1005902 |
0.534 |
|
| 2016 |
Eickhoff CS, Zhang X, Vasconcelos JR, Motz RG, Sullivan NL, O'Shea K, Pozzi N, Gohara DW, Blase JR, Di Cera E, Hoft DF. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity. Plos Pathogens. 12: e1005896. PMID 27642757 DOI: 10.1371/Journal.Ppat.1005896 |
0.785 |
|
| 2016 |
Hoft DF, Lottenbach K, Goll JB, Hill H, Winokur PL, Patel SM, Brady RC, Chen WH, Edwards K, Creech CB, Frey SE, Blevins TP, Salomon R, Belshe RB. Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. The Journal of Infectious Diseases. PMID 27443611 DOI: 10.1093/Infdis/Jiw310 |
0.461 |
|
| 2016 |
Suliman S, Geldenhuys H, Johnson JL, Hughes JE, Smit E, Murphy M, Toefy A, Lerumo L, Hopley C, Pienaar B, Chheng P, Nemes E, Hoft DF, Hanekom WA, Boom WH, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 27412415 DOI: 10.4049/Jimmunol.1501996 |
0.435 |
|
| 2016 |
Hoft DF, Blazevic A, Selimovic A, Turan A, Tennant J, Abate G, Fulkerson J, Zak DE, Walker R, McClain B, Sadoff J, Scott J, Shepherd B, Ishmukhamedov J, Hokey DA, et al. Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial. Ebiomedicine. 7: 278-286. PMID 27322481 DOI: 10.1016/J.Ebiom.2016.04.010 |
0.356 |
|
| 2016 |
Xia M, Hesser DC, De P, Sakala IG, Spencer CT, Kirkwood JS, Abate G, Chatterjee D, Dobos KM, Hoft DF. A Subset of Protective γ9δ2 T cells is Activated by Novel Mycobacterial Lipid Components. Infection and Immunity. PMID 27297390 DOI: 10.1128/Iai.01322-15 |
0.75 |
|
| 2016 |
Sharma J, Blase JR, Hoft DF, Marentette JO, Turk J, McHowat J. Mice with Genetic Deletion of Group VIA Phospholipase A2β Exhibit Impaired Macrophage Function and Increased Parasite Load in Trypanosoma cruzi-Induced Myocarditis. Infection and Immunity. 84: 1137-42. PMID 26857573 DOI: 10.1128/Iai.01564-15 |
0.363 |
|
| 2016 |
Hoft DF, Blazevic A, Selimovic A, Turan A, Tennant J, Abate G, Fulkerson J, Zak DE, Walker R, McClain B, Sadoff J, Scott J, Shepherd B, Ishmukhamedov J, Hokey DA, et al. Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial Ebiomedicine. DOI: 10.1016/j.ebiom.2016.04.010 |
0.349 |
|
| 2015 |
Abate G, Spencer CT, Hamzabegovic F, Blazevic A, Xia M, Hoft DF. Mycobacteria-specific γ9δ2 T cells mediate both pathogen inhibitory and CD40L-dependent antigen presentation effects important for TB immunity. Infection and Immunity. PMID 26644385 DOI: 10.1128/Iai.01262-15 |
0.742 |
|
| 2015 |
Abate G, Ruminiski PG, Kumar M, Singh K, Hamzabegovic F, Hoft DF, Eickhoff CS, Selimovic A, Campbell M, Chibale K. New verapamil analogs inhibit intracellular mycobacteria without affecting the functions of mycobacteria-specific T cells. Antimicrobial Agents and Chemotherapy. PMID 26643325 DOI: 10.1128/Aac.01567-15 |
0.399 |
|
| 2015 |
Eickhoff CS, Van Aartsen D, Terry FE, Meymandi SK, Traina MM, Hernandez S, Martin WD, Moise L, De Groot AS, Hoft DF. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes. Human Vaccines & Immunotherapeutics. 0. PMID 26107442 DOI: 10.1080/21645515.2015.1061160 |
0.499 |
|
| 2015 |
Sakala IG, Kjer-Nielsen L, Eickhoff CS, Wang X, Blazevic A, Liu L, Fairlie DP, Rossjohn J, McCluskey J, Fremont DH, Hansen TH, Hoft DF. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. Journal of Immunology (Baltimore, Md. : 1950). 195: 587-601. PMID 26063000 DOI: 10.4049/Jimmunol.1402545 |
0.457 |
|
| 2015 |
Huang Y, Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Hunborg P, Varvares MA, Hoft DF, Hsueh EC, Peng G. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. Oncotarget. PMID 25968569 DOI: 10.18632/Oncotarget.3958 |
0.373 |
|
| 2015 |
Sullivan NL, Eickhoff CS, Sagartz J, Hoft DF. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion. Journal of Immunology (Baltimore, Md. : 1950). 194: 1806-18. PMID 25595788 DOI: 10.4049/Jimmunol.1303163 |
0.765 |
|
| 2015 |
Behr M, Ellis R, Ernst J, Evans T, Flynn J, Hatherill M, Hoft D, Lalvani A, McShane H, Nardell E, Ordway D, Ramanathan R, Ruhwald M, Schlesinger L, Self S, et al. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings. National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014. Vaccine. 33: 3056-3064. DOI: 10.1016/J.Vaccine.2015.03.061 |
0.436 |
|
| 2015 |
Achkar J, Beverley P, Boom H, Evans T, Hanekom W, Hickey A, Hoft D, Lakhani D, Lin PL, Ramanathan R, Henao-Restrepo AM, Roy C, Schlesinger L, Seder R, Silver R, et al. Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings. National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, April 9, 2014. Vaccine. 33: 3038-3046. DOI: 10.1016/J.Vaccine.2015.03.060 |
0.401 |
|
| 2014 |
Ye J, Ma C, Hsueh EC, Dou J, Mo W, Liu S, Han B, Huang Y, Zhang Y, Varvares MA, Hoft DF, Peng G. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence. Embo Molecular Medicine. 6: 1294-311. PMID 25231413 DOI: 10.15252/Emmm.201403918 |
0.372 |
|
| 2014 |
Hoft DF. Development of vaccines to control the worldwide tuberculosis pandemic. Missouri Medicine. 111: 326-31. PMID 25211863 |
0.333 |
|
| 2014 |
Hoft DF, Belshe RB. Progress toward the development of universal influenza vaccines. Missouri Medicine. 111: 321-5. PMID 25211862 |
0.331 |
|
| 2014 |
Abate G, Hoft DF. Variations between bacillus Calmette-Guérin strains: lessons from tuberculosis prevention. European Urology. 66: 692-3. PMID 24985963 DOI: 10.1016/J.Eururo.2014.06.006 |
0.329 |
|
| 2014 |
Hatherill M, Geldenhuys H, Pienaar B, Suliman S, Chheng P, Debanne SM, Hoft DF, Boom WH, Hanekom WA, Johnson JL. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults. Vaccine. 32: 3982-8. PMID 24814553 DOI: 10.1016/J.Vaccine.2014.04.084 |
0.423 |
|
| 2014 |
Sharma J, Eickhoff CS, Hoft DF, Marentette JO, Turk J, McHowat J. Absence of calcium-independent phospholipase A2 β impairs platelet-activating factor production and inflammatory cell recruitment in Trypanosoma cruzi-infected endothelial cells. Physiological Reports. 2: e00196. PMID 24744875 DOI: 10.1002/Phy2.196 |
0.382 |
|
| 2014 |
Seaworth BJ, Armitige LY, Aronson NE, Hoft DF, Fleenor ME, Gardner AF, Harris DA, Stricof RL, Nardell EA. Multidrug-resistant tuberculosis. Recommendations for reducing risk during travel for healthcare and humanitarian work. Annals of the American Thoracic Society. 11: 286-95. PMID 24673692 DOI: 10.1513/Annalsats.201309-312Ps |
0.334 |
|
| 2014 |
Blazevic A, Eickhoff CS, Stanley J, Buller MR, Schriewer J, Kettelson EM, Hoft DF. Investigations of TB vaccine-induced mucosal protection in mice. Microbes and Infection / Institut Pasteur. 16: 73-9. PMID 24120457 DOI: 10.1016/J.Micinf.2013.09.006 |
0.527 |
|
| 2013 |
Fletcher HA, Tanner R, Wallis RS, Meyer J, Manjaly ZR, Harris S, Satti I, Silver RF, Hoft D, Kampmann B, Walker KB, Dockrell HM, Fruth U, Barker L, Brennan MJ, et al. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clinical and Vaccine Immunology : Cvi. 20: 1683-9. PMID 23986316 DOI: 10.1128/Cvi.00427-13 |
0.467 |
|
| 2013 |
Ye J, Ma C, Wang F, Hsueh EC, Toth K, Huang Y, Mo W, Liu S, Han B, Varvares MA, Hoft DF, Peng G. Specific recruitment of γδ regulatory T cells in human breast cancer. Cancer Research. 73: 6137-48. PMID 23959855 DOI: 10.1158/0008-5472.Can-13-0348 |
0.354 |
|
| 2013 |
Eickhoff CS, Schnapp AR, Sagartz JE, Hoft DF. Lethal NK-mediated inflammation induced by IL-12 in the absence of polymorphic and nonpolymorphic MHC class I molecules. Cytokine. 64: 25-9. PMID 23891392 DOI: 10.1016/J.Cyto.2013.06.320 |
0.398 |
|
| 2013 |
Eickhoff CS, Dunn BA, Sullivan NL, Hoft DF. Comparison of the infectivity of Trypanosoma cruzi insect-derived metacyclic trypomastigotes after mucosal and cutaneous contaminative challenges. Memã³Rias Do Instituto Oswaldo Cruz. 108: 508-11. PMID 23828001 DOI: 10.1590/S0074-02762013000400018 |
0.698 |
|
| 2013 |
Qian X, Gu L, Ning H, Zhang Y, Hsueh EC, Fu M, Hu X, Wei L, Hoft DF, Liu J. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Journal of Immunology (Baltimore, Md. : 1950). 190: 5894-902. PMID 23645882 DOI: 10.4049/Jimmunol.1203141 |
0.302 |
|
| 2013 |
Sakala IG, Eickhoff CS, Blazevic A, Moheno P, Silver RF, Hoft DF. Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide. Infection and Immunity. 81: 1974-83. PMID 23509148 DOI: 10.1128/Iai.01393-12 |
0.319 |
|
| 2013 |
Sharma J, Eickhoff CS, Hoft DF, Ford DA, Gross RW, McHowat J. The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection. Infection and Immunity. 81: 2278-87. PMID 23429536 DOI: 10.1128/Iai.00497-12 |
0.4 |
|
| 2013 |
Ye J, Ma C, Hsueh EC, Eickhoff CS, Zhang Y, Varvares MA, Hoft DF, Peng G. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. Journal of Immunology (Baltimore, Md. : 1950). 190: 2403-14. PMID 23355732 DOI: 10.4049/Jimmunol.1202369 |
0.482 |
|
| 2013 |
Spencer CT, Abate G, Sakala IG, Xia M, Truscott SM, Eickhoff CS, Linn R, Blazevic A, Metkar SS, Peng G, Froelich CJ, Hoft DF. Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen. Plos Pathogens. 9: e1003119. PMID 23326234 DOI: 10.1371/Journal.Ppat.1003119 |
0.718 |
|
| 2013 |
Ye J, Ma C, Hsueh EC, Zhang Y, Varvares MA, Hoft DF, Peng G. Abstract 4995: Tumor-dervied gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. Cancer Research. 73: 4995-4995. DOI: 10.1158/1538-7445.Am2013-4995 |
0.486 |
|
| 2012 |
Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Wevers E, Schwartz T, Hunborg P, Varvares MA, Hoft DF, Hsueh EC, Peng G. Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer. Journal of Immunology (Baltimore, Md. : 1950). 189: 5029-36. PMID 23034170 DOI: 10.4049/Jimmunol.1201892 |
0.376 |
|
| 2012 |
Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infection and Immunity. 80: 3256-67. PMID 22778103 DOI: 10.1128/Iai.00279-12 |
0.507 |
|
| 2012 |
Ye J, Huang X, Hsueh EC, Zhang Q, Ma C, Zhang Y, Varvares MA, Hoft DF, Peng G. Human regulatory T cells induce T-lymphocyte senescence. Blood. 120: 2021-31. PMID 22723548 DOI: 10.1182/Blood-2012-03-416040 |
0.497 |
|
| 2012 |
Hoft DF, Blazevic A, Stanley J, Landry B, Sizemore D, Kpamegan E, Gearhart J, Scott A, Kik S, Pau MG, Goudsmit J, McClain JB, Sadoff J. A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity. Vaccine. 30: 2098-108. PMID 22296955 DOI: 10.1016/J.Vaccine.2012.01.048 |
0.441 |
|
| 2012 |
Ma C, Zhang Q, Ye J, Zhang Y, Wevers E, Schwartz T, Hunborg P, Vavares MA, Hoft DF, Hsueh EC, Peng G. Abstract 3544: Role of tumor-infiltrating gammadelta T lymphocytes in breast cancer Cancer Research. 72: 3544-3544. DOI: 10.1158/1538-7445.Am2012-3544 |
0.35 |
|
| 2011 |
Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, Truscott SM, Abate G, Sakala IG, Edwards KM, Buddy Creech C, Gerber MA, Bernstein DI, Newman F, Graham I, Anderson EL, et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children Journal of Infectious Diseases. 204: 845-853. PMID 21846636 DOI: 10.1093/Infdis/Jir436 |
0.703 |
|
| 2011 |
Sullivan NL, Eickhoff CS, Zhang X, Giddings OK, Lane TE, Hoft DF. Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation. Journal of Immunology (Baltimore, Md. : 1950). 187: 1358-68. PMID 21715689 DOI: 10.4049/Jimmunol.1100033 |
0.788 |
|
| 2011 |
Hoft DF, Brusic V, Sakala IG. Optimizing vaccine development. Cellular Microbiology. 13: 934-42. PMID 21631691 DOI: 10.1111/J.1462-5822.2011.01609.X |
0.422 |
|
| 2011 |
Qian X, Ning H, Zhang J, Hoft DF, Stumpo DJ, Blackshear PJ, Liu J. Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin. Journal of Immunology (Baltimore, Md. : 1950). 186: 6454-64. PMID 21515794 DOI: 10.4049/Jimmunol.1002672 |
0.303 |
|
| 2011 |
Zhang J, Qian X, Ning H, Eickhoff CS, Hoft DF, Liu J. Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding. Journal of Immunology (Baltimore, Md. : 1950). 186: 5885-95. PMID 21482740 DOI: 10.4049/Jimmunol.1003447 |
0.339 |
|
| 2011 |
Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, Hoft DF. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. Plos Neglected Tropical Diseases. 5: e983. PMID 21408124 DOI: 10.1371/Journal.Pntd.0000983 |
0.715 |
|
| 2011 |
Ye J, Su X, Hsueh EC, Zhang Y, Koenig JM, Hoft DF, Peng G. Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function. European Journal of Immunology. 41: 936-51. PMID 21381020 DOI: 10.1002/Eji.201040682 |
0.422 |
|
| 2011 |
Ye J, Su X, Hsueh EC, Zhang Y, Koenig JM, Hoft DF, Peng G. Abstract 781: Plasticity of human tumor-infiltrating Th17 cells Cancer Research. 71: 781-781. DOI: 10.1158/1538-7445.Am2011-781 |
0.401 |
|
| 2010 |
Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF. CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infection and Immunity. 78: 5295-306. PMID 20921150 DOI: 10.1128/Iai.00513-10 |
0.483 |
|
| 2010 |
Eickhoff CS, Giddings OK, Yoshida N, Hoft DF. Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection. MemóRias Do Instituto Oswaldo Cruz. 105: 687-91. PMID 20835618 DOI: 10.1590/S0074-02762010000500015 |
0.798 |
|
| 2010 |
Eickhoff CS, Lawrence CT, Sagartz JE, Bryant LA, Labovitz AJ, Gala SS, Hoft DF. ECG detection of murine chagasic cardiomyopathy. The Journal of Parasitology. 96: 758-64. PMID 20738200 DOI: 10.1645/Ge-2396.1 |
0.459 |
|
| 2010 |
Giddings OK, Eickhoff CS, Sullivan NL, Hoft DF. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infection and Immunity. 78: 1333-8. PMID 20048046 DOI: 10.1128/Iai.00278-09 |
0.808 |
|
| 2010 |
Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 1630-41. PMID 20026736 DOI: 10.4049/Jimmunol.0902813 |
0.337 |
|
| 2009 |
Frey SE, Newman FK, Kennedy JS, Ennis F, Abate G, Hoft DF, Monath TP. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. Vaccine. 27: 1637-44. PMID 19071184 DOI: 10.1016/J.Vaccine.2008.11.079 |
0.471 |
|
| 2008 |
Gaseitsiwe S, Valentini D, Mahdavifar S, Magalhaes I, Hoft DF, Zerweck J, Schutkowski M, Andersson J, Reilly M, Maeurer MJ. Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis. Plos One. 3: e3840. PMID 19065269 DOI: 10.1371/Journal.Pone.0003840 |
0.395 |
|
| 2008 |
Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. The Journal of Infectious Diseases. 198: 1491-501. PMID 18808333 DOI: 10.1086/592450 |
0.441 |
|
| 2008 |
Spencer CT, Abate G, Blazevic A, Hoft DF. Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity. Journal of Immunology (Baltimore, Md. : 1950). 181: 4471-84. PMID 18802050 DOI: 10.4049/Jimmunol.181.7.4471 |
0.747 |
|
| 2008 |
Hoft DF. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet (London, England). 372: 164-75. PMID 18620952 DOI: 10.1016/S0140-6736(08)61036-3 |
0.491 |
|
| 2008 |
Hanekom WA, Dockrell HM, Ottenhoff TH, Doherty TM, Fletcher H, McShane H, Weichold FF, Hoft DF, Parida SK, Fruth UJ. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. Plos Medicine. 5: e145. PMID 18597551 DOI: 10.1371/Journal.Pmed.0050145 |
0.475 |
|
| 2008 |
Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, Hoft DF, Ray R. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. Journal of Virology. 82: 3320-8. PMID 18216090 DOI: 10.1128/Jvi.02547-07 |
0.365 |
|
| 2007 |
Hoft DF, Eickhoff CS, Giddings OK, Vasconcelos JR, Rodrigues MM. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. Journal of Immunology (Baltimore, Md. : 1950). 179: 6889-900. PMID 17982080 DOI: 10.4049/Jimmunol.179.10.6889 |
0.822 |
|
| 2007 |
Duthie MS, Goto W, Ireton GC, Reece ST, Cardoso LP, Martelli CM, Stefani MM, Nakatani M, de Jesus RC, Netto EM, Balagon MV, Tan E, Gelber RH, Maeda Y, Makino M, ... Hoft D, et al. Use of protein antigens for early serological diagnosis of leprosy. Clinical and Vaccine Immunology : Cvi. 14: 1400-8. PMID 17898185 DOI: 10.1128/Cvi.00299-07 |
0.317 |
|
| 2006 |
Giddings OK, Eickhoff CS, Smith TJ, Bryant LA, Hoft DF. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infection and Immunity. 74: 5549-60. PMID 16988230 DOI: 10.1128/Iai.00319-06 |
0.808 |
|
| 2005 |
de Vallière S, Abate G, Blazevic A, Heuertz RM, Hoft DF. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infection and Immunity. 73: 6711-20. PMID 16177348 DOI: 10.1128/Iai.73.10.6711-6720.2005 |
0.495 |
|
| 2005 |
Abate G, Eslick J, Newman FK, Frey SE, Belshe RB, Monath TP, Hoft DF. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. The Journal of Infectious Diseases. 192: 1362-71. PMID 16170753 DOI: 10.1086/444423 |
0.461 |
|
| 2005 |
Araújo AF, de Alencar BC, Vasconcelos JR, Hiyane MI, Marinho CR, Penido ML, Boscardin SB, Hoft DF, Gazzinelli RT, Rodrigues MM. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infection and Immunity. 73: 6017-25. PMID 16113322 DOI: 10.1128/Iai.73.9.6017-6025.2005 |
0.569 |
|
| 2005 |
Hoft DF, Eickhoff CS. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infection and Immunity. 73: 4934-40. PMID 16041007 DOI: 10.1128/Iai.73.8.4934-4940.2005 |
0.52 |
|
| 2003 |
Eickhoff CS, Eckmann L, Hoft DF. Differential interleukin-8 and nitric oxide production in epithelial cells induced by mucosally invasive and noninvasive Trypanosoma cruzi trypomastigotes. Infection and Immunity. 71: 5394-7. PMID 12933891 DOI: 10.1128/Iai.71.9.5394-5397.2003 |
0.365 |
|
| 2003 |
Worku S, Hoft DF. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infection and Immunity. 71: 1763-73. PMID 12654790 DOI: 10.1128/Iai.71.4.1763-1773.2003 |
0.544 |
|
| 2003 |
Brown RM, Cruz O, Brennan M, Gennaro ML, Schlesinger L, Skeiky YA, Hoft DF. Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination. The Journal of Infectious Diseases. 187: 513-7. PMID 12552438 DOI: 10.1086/368096 |
0.493 |
|
| 2003 |
Hoft DF, Eickhoff CS. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infection and Immunity. 70: 6715-25. PMID 12438346 DOI: 10.1128/Iai.70.12.6715-6725.2002 |
0.542 |
|
| 2002 |
Hoft DF, Worku S, Kampmann B, Whalen CC, Ellner JJ, Hirsch CS, Brown RB, Larkin R, Li Q, Yun H, Silver RF. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. The Journal of Infectious Diseases. 186: 1448-57. PMID 12404160 DOI: 10.1086/344359 |
0.508 |
|
| 2002 |
Schnapp AR, Eickhoff CS, Scharfstein J, Hoft DF. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection. Microbes and Infection / Institut Pasteur. 4: 805-13. PMID 12270727 DOI: 10.1016/S1286-4579(02)01600-3 |
0.598 |
|
| 2002 |
Schnapp AR, Eickhoff CS, Sizemore D, Curtiss R, Hoft DF. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infection and Immunity. 70: 5065-74. PMID 12183554 DOI: 10.1128/Iai.70.9.5065-5074.2002 |
0.634 |
|
| 2002 |
Cheon SH, Kampmann B, Hise AG, Phillips M, Song HY, Landen K, Li Q, Larkin R, Ellner JJ, Silver RF, Hoft DF, Wallis RS. Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clinical and Diagnostic Laboratory Immunology. 9: 901-7. PMID 12093693 DOI: 10.1128/Cdli.9.4.901-907.2002 |
0.472 |
|
| 2001 |
Worku S, Gorse GJ, Belshe RB, Hoft DF. Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production. The Journal of Infectious Diseases. 184: 525-32. PMID 11474428 DOI: 10.1086/322792 |
0.577 |
|
| 2001 |
Ray R, Hoft DF, Meyer K, Brown R, Lagging LM, Belshe RB. Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus. Virus Research. 75: 147-54. PMID 11325469 DOI: 10.1016/S0168-1702(01)00237-4 |
0.496 |
|
| 2000 |
Worku S, Hoft DF. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S257-61. PMID 10875795 DOI: 10.1086/313887 |
0.574 |
|
| 2000 |
Hoft DF, Brown RM, Belshe RB. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S217-22. PMID 10875787 DOI: 10.1086/313864 |
0.457 |
|
| 2000 |
Falk LA, Goldenthal KL, Esparza J, Aguado MT, Osmanov S, Ballou WR, Beddows S, Bhamarapravati N, Biberfeld G, Ferrari G, Hoft D, Honda M, Jackson A, Lu Y, Marchal G, et al. Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines Aids Research and Human Retroviruses. 16: 91-98. PMID 10659047 DOI: 10.1089/088922200309421 |
0.368 |
|
| 2000 |
Hoft DF, Schnapp AR, Eickhoff CS, Roodman ST. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infection and Immunity. 68: 197-204. PMID 10603388 DOI: 10.1128/Iai.68.1.197-204.2000 |
0.539 |
|
| 1999 |
Hoft DF, Leonardi C, Milligan T, Nahass GT, Kemp B, Cook S, Tennant J, Carey M. Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 28: 785-90. PMID 10825039 DOI: 10.1086/515201 |
0.433 |
|
| 1999 |
Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination. The Journal of Laboratory and Clinical Medicine. 134: 244-52. PMID 10482309 DOI: 10.1016/S0022-2143(99)90204-4 |
0.466 |
|
| 1999 |
Hoft DF, Tennant JM. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity. Annals of Internal Medicine. 131: 32-6. PMID 10391813 DOI: 10.7326/0003-4819-131-1-199907060-00007 |
0.425 |
|
| 1996 |
Hoft DF. Differential mucosal infectivity of different life stages of Trypanosoma cruzi. The American Journal of Tropical Medicine and Hygiene. 55: 360-4. PMID 8916789 DOI: 10.4269/Ajtmh.1996.55.360 |
0.411 |
|
| 1996 |
Hoft DF, Farrar PL, Kratz-Owens K, Shaffer D. Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses. Infection and Immunity. 64: 3800-10. PMID 8751932 DOI: 10.1128/Iai.64.9.3800-3810.1996 |
0.493 |
|
| 1996 |
Kemp EB, Belshe RB, Hoft DF. Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin. The Journal of Infectious Diseases. 174: 113-9. PMID 8655980 DOI: 10.1093/Infdis/174.1.113 |
0.495 |
|
| 1995 |
Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. Journal of Virology. 69: 5859-63. PMID 7637033 DOI: 10.1128/Jvi.69.9.5859-5863.1995 |
0.319 |
|
| 1995 |
Hoft DF, Donelson JE, Kirchhoff LV. Repetitive protein antigens of Trypanosoma cruzi have diverse intracellular locations. The Journal of Parasitology. 81: 549-54. PMID 7623195 DOI: 10.2307/3283851 |
0.332 |
|
| 1990 |
Kirchhoff LV, Hoft DF. Immunization and challenge of mice with insect-derived metacyclic trypomastigotes of Trypanosoma cruzi. Parasite Immunology. 12: 65-74. PMID 2107500 DOI: 10.1111/J.1365-3024.1990.Tb00936.X |
0.441 |
|
| 1989 |
Hoft DF, Kim KS, Otsu K, Moser DR, Yost WJ, Blumin JH, Donelson JE, Kirchhoff LV. Trypanosoma cruzi expresses diverse repetitive protein antigens Infection and Immunity. 57: 1959-1967. PMID 2659529 DOI: 10.1128/Iai.57.7.1959-1967.1989 |
0.339 |
|
| Show low-probability matches. |